Teladoc Health to Participate in Upcoming Investor Conference
Rhea-AI Summary
Teladoc Health (NYSE: TDOC) said CEO Chuck Divita will present at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco on Monday, January 12, 2026 at 3:45 p.m. PT (6:45 p.m. ET). A live audio webcast and replay will be available on the company's investor relations site.
Investors can listen live or view the replay at the investor events page: https://ir.teladochealth.com/news-and-events/events-and-presentations.
Positive
- None.
Negative
- None.
News Market Reaction 40 Alerts
On the day this news was published, TDOC gained 3.26%, reflecting a moderate positive market reaction. Argus tracked a peak move of +5.9% during that session. Our momentum scanner triggered 40 alerts that day, indicating elevated trading interest and price volatility. This price movement added approximately $45M to the company's valuation, bringing the market cap to $1.43B at that time. Trading volume was above average at 1.8x the daily average, suggesting increased trading activity.
Data tracked by StockTitan Argus on the day of publication.
NEW YORK, Jan. 05, 2026 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE: TDOC), the global leader in virtual care, announced today that Chuck Divita, chief executive officer, will participate in the 44th Annual J.P. Morgan Healthcare Conference in San Francisco on Monday, January 12, 2026, at 3:45 p.m. PT (6:45 p.m. ET). A live audio webcast and replay of the presentation will be available at https://ir.teladochealth.com/news-and-events/events-and-presentations.
About Teladoc Health
Teladoc Health (NYSE: TDOC) is the global leader in virtual care. The company is delivering and orchestrating care across patients, care providers, platforms, and partners — transforming virtual care into a catalyst for how better health happens. Through our relationships with health plans, employers, providers, health systems and consumers, we are enabling more access, driving better outcomes, extending provider capacity and lowering costs. Learn more at teladochealth.com.
Investors:
Michael Minchak
ir@teladochealth.com
617-444-9612